PH20852A - 1,3-oxazolidine-2-one derivatives and processes for their preparation - Google Patents

1,3-oxazolidine-2-one derivatives and processes for their preparation

Info

Publication number
PH20852A
PH20852A PH32310A PH32310A PH20852A PH 20852 A PH20852 A PH 20852A PH 32310 A PH32310 A PH 32310A PH 32310 A PH32310 A PH 32310A PH 20852 A PH20852 A PH 20852A
Authority
PH
Philippines
Prior art keywords
oxazolidine
derivatives
processes
preparation
Prior art date
Application number
PH32310A
Other languages
English (en)
Inventor
Masaki Mitsuo
Shinozaki Haruhiko
Satoh Masaru
Moritoh Naoya
Hashimoto Koichi
Kamishiro Toshiro
Original Assignee
Nippon Chemiphar Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Chemiphar Co filed Critical Nippon Chemiphar Co
Publication of PH20852A publication Critical patent/PH20852A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/22—Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PH32310A 1984-09-28 1985-05-24 1,3-oxazolidine-2-one derivatives and processes for their preparation PH20852A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59203624A JPS6183170A (ja) 1984-09-28 1984-09-28 新規な１，３−オキサゾリジン−２−オン誘導体およびその製造法

Publications (1)

Publication Number Publication Date
PH20852A true PH20852A (en) 1987-05-19

Family

ID=16477122

Family Applications (1)

Application Number Title Priority Date Filing Date
PH32310A PH20852A (en) 1984-09-28 1985-05-24 1,3-oxazolidine-2-one derivatives and processes for their preparation

Country Status (27)

Country Link
US (1) US4644063A (de)
JP (1) JPS6183170A (de)
KR (1) KR900004323B1 (de)
AR (1) AR240924A1 (de)
AT (1) AT392069B (de)
AU (1) AU566419B2 (de)
BR (1) BR8502707A (de)
CA (1) CA1252092A (de)
CH (1) CH663207A5 (de)
CS (1) CS273606B2 (de)
DE (1) DE3519261C2 (de)
DK (1) DK165952C (de)
ES (2) ES8800571A1 (de)
FR (1) FR2571052B1 (de)
GB (2) GB8512975D0 (de)
HU (1) HU199132B (de)
IN (1) IN162060B (de)
IT (1) IT1208807B (de)
MX (2) MX161397A (de)
MY (1) MY102081A (de)
NL (1) NL193191C (de)
NZ (1) NZ212143A (de)
PH (1) PH20852A (de)
RO (1) RO91422B (de)
SE (1) SE463100B (de)
SU (2) SU1402263A3 (de)
ZA (1) ZA854001B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6183147A (ja) * 1984-09-28 1986-04-26 Nippon Chemiphar Co Ltd 新規なアミノアルコール誘導体およびその製造法並びにそれを有効成分とするグルタミン酸遮断剤
JPH0759570B2 (ja) * 1986-05-06 1995-06-28 三井東圧化学株式会社 ２−オキサゾリジノン類の製造方法
JPH0713017B2 (ja) * 1986-06-18 1995-02-15 日本ケミファ株式会社 脳細胞保護作用を有する医薬組成物
DE3877470T2 (de) * 1987-09-10 1993-06-24 Merck Sharp & Dohme Oxazole und thiazole zur behandlung seniler demenz.
ATE106243T1 (de) * 1988-03-24 1994-06-15 Sankyo Co Verwendung von isoxazolinonen als cerebro-aktive medikamente.
JPH0314562A (ja) * 1988-04-11 1991-01-23 Nippon Chemiphar Co Ltd 新規なアルキレンジアミン誘導体およびグルタミン酸遮断剤
US5187171A (en) * 1989-01-09 1993-02-16 G. D. Searle & Co. Use of a glycine b partial agonist as an antipsychotic
ATE170516T1 (de) * 1992-07-14 1998-09-15 Nippon Chemiphar Co Alkylendiaminderivate
US5698573A (en) * 1993-09-15 1997-12-16 Merck, Sharp & Dohme, Ltd. Imidazolone and oxazolone derivatives as dopamine antagonists
DE4425613A1 (de) * 1994-07-20 1996-01-25 Bayer Ag 5-gliedrige Heteroaryl-oxazolidinone
US6037354A (en) * 1997-06-18 2000-03-14 Merck & Co., Inc. Alpha 1a adrenergic receptor antagonists
US9717239B2 (en) 2013-03-14 2017-08-01 Akzo Nobel Chemicals International B.V. Cellulose ether as a drift control agent and rainfastness agent

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2437389A (en) * 1948-03-09 Oxazoeidones and erocesstok
DE1135461B (de) * 1959-05-08 1962-08-30 Knoll Ag Verfahren zur Herstellung von basisch substituierten Phthalimidinen
FR1301267A (fr) * 1961-04-04 1962-08-17 Science Union Et Compagnie Soc Nouveaux dérivés de l'oxazolidinone-2 et leurs procédés de préparation
US3131197A (en) * 1963-03-13 1964-04-28 Smith Kline French Lab 5-(3, 4-carbonyldioxyphenyl)-3-isopropyl-2-oxazolidone
US3576808A (en) * 1967-09-15 1971-04-27 Miles Lab N-4-phenyl-1-piperazinylalkyl-5-phenyl-oxazolidinones
GB1222708A (en) * 1968-10-22 1971-02-17 Delalande Sa Novel 5-(n-substituted aminomethyl)-2-oxazolidinones and their process of preparation
FR2179582B1 (de) * 1972-04-13 1975-10-10 Synthelabo

Also Published As

Publication number Publication date
ES557075A0 (es) 1988-04-01
GB2165237A (en) 1986-04-09
ATA165685A (de) 1990-07-15
HUT39168A (en) 1986-08-28
AU4469785A (en) 1986-04-10
JPH0469150B2 (de) 1992-11-05
GB8512975D0 (en) 1985-06-26
JPS6183170A (ja) 1986-04-26
IT8567500A0 (it) 1985-05-30
NL8501579A (nl) 1986-04-16
SU1431679A3 (ru) 1988-10-15
GB8513685D0 (en) 1985-07-03
RO91422A (ro) 1987-06-30
AU566419B2 (en) 1987-10-22
GB2165237B (en) 1987-12-09
US4644063A (en) 1987-02-17
CS273606B2 (en) 1991-03-12
ES8802152A1 (es) 1988-04-01
IT1208807B (it) 1989-07-10
AT392069B (de) 1991-01-25
SU1402263A3 (ru) 1988-06-07
DE3519261A1 (de) 1986-04-10
CH663207A5 (fr) 1987-11-30
AR240924A2 (es) 1991-03-27
CS392785A2 (en) 1990-08-14
DK165952B (da) 1993-02-15
KR900004323B1 (ko) 1990-06-22
HU199132B (en) 1990-01-29
MY102081A (en) 1992-03-31
KR860002502A (ko) 1986-04-26
DE3519261C2 (de) 1997-01-16
MX21592A (es) 1994-01-31
CA1252092A (en) 1989-04-04
NL193191B (nl) 1998-10-01
ES543517A0 (es) 1987-11-01
SE463100B (sv) 1990-10-08
MX161397A (es) 1990-09-20
NZ212143A (en) 1987-11-27
RO91422B (ro) 1987-07-02
DK230185A (da) 1986-03-29
NL193191C (nl) 1999-02-02
BR8502707A (pt) 1986-05-27
SE8502525L (sv) 1986-03-29
ZA854001B (en) 1986-01-29
DK165952C (da) 1993-07-05
FR2571052B1 (fr) 1988-03-04
FR2571052A1 (fr) 1986-04-04
IN162060B (de) 1988-03-19
AR240924A1 (es) 1991-03-27
DK230185D0 (da) 1985-05-23
SE8502525D0 (sv) 1985-05-22
ES8800571A1 (es) 1987-11-01

Similar Documents

Publication Publication Date Title
GB2153821B (en) 3-imidazolylmethyl-1,2,3,9-tetrahydro-4h-carbazol-4-one derivatives
EG17339A (en) 1,4-dihydro-4-oxonaphthyridine derivatives and salts thereof
DE3563623D1 (en) Novel 1,5-benzothiazepine derivatives, processes for preparing the same and pharmaceutical compositions
GB2159520B (en) 1, 24-dihydroxy- 22-vitamin d3 and process for preparing same
PH20852A (en) 1,3-oxazolidine-2-one derivatives and processes for their preparation
DE3560679D1 (en) 4-hydroxy-2h-1-benzothiopyran-2-one derivatives, their preparation and uses
IL74133A0 (en) Azolyl-aryl-alkanol derivatives,processes for their preparation and their use
DE3567638D1 (en) 2,4-dichloro-3-alkyl-6-nitrophenols and process for their preparation
EP0177245A3 (en) Amino-alcohol derivatives and processes for their preparation
EP0183975A3 (en) 5,6,7,8-tetrafluoroanthraquinone derivatives
HK185395A (en) 9,11-Epoxy-21-hydroxypregnane derivatives
ZA851949B (en) 1,2,4-triazacycloalkadiene derivatives
DE3661830D1 (en) 2,4-dichlorothiazole derivatives and process for their preparation
DE3561058D1 (en) Hydroxy-thia-alcanes, process for their preparation and their uses
HUT38906A (en) Process for preparing 1,3-oxyacyl-2-oxindole derivatives
GB2185257B (en) 10 beta-alkynyl-4, 9(11)-estradiene derivatives and process for their preparation
GB2165242B (en) Process for the preparation of 1, 2-benzoxathiine derivatives
ZA852968B (en) 2,3-diamino-2,3-didesoxyhexose derivatives,processes for their preparation and their use
PT81633A (en) Process for the preparation of 1,4-dihydropiridine derivatives
GB8507490D0 (en) Preparing 2 2-bishalomethylpenam derivatives
EP0173754A4 (de) 7-thiaprostaglandine e1 und deren herstellung.
HUT37934A (en) Process for preparing 1,4-dihydro-pyridina derivatives
IE841028L (en) 5,6-dihydropyran-2-one derivatives
IE841962L (en) 1,6 - naphtyridinone derivatives
IE841963L (en) 1,6 - naphthyridinone derivatives